Home Medtronic's Penditure Left Atrial Appendage Exclusion System Receives CE Mark Approval

Medtronic's Penditure Left Atrial Appendage Exclusion System Receives CE Mark Approval

Oct 02, 2025 22:15 CST Updated 22:15
Medtronic

Medical Device Manufacturer

Medtronic announced that itsLeft Atrial Appendage Closure Device---PenditureReceived CE approval for marketing. Previously, it had already been approved by the FDA.Penditure has been launched, and currently, the product has surpassed 10,000 units in global sales.

图片

PenditureOriginated from Medtronic2023August from a well-known incubatorAcquired by Syntheon, AcquisitionPenditureIs to strengthen itsHeartSurgical Business

SyntheonIt is a medical device incubator established in 1999, which collaborates with many industry giants such as Johnson & Johnson, Boston Scientific, Medtronic, Edwards, and Olympus.
图片
SyntheonThe innovative products developed have provided treatment for 52 million patients and generated sales exceeding 6 billion US dollars. Additionally, more than 200 invention patents have been filed.
图片
SyntheonIn addition to having strong innovative capabilities, it also possesses robust manufacturing capabilities.Manufacturing CapabilityIt is something that general incubators rarely have.

In the field of left atrial appendage closure, Medtronic does not have much advantage and is considered a follower.The field of left atrial appendage closure is basically dominated by Boston Scientific.Watchman series and Abbott'sMonopolized by Amplatzer Amulet. And Johnson & Johnson also spent$400 Million Acquisition of LamInar Enters the Chinese MarketIn the field of left atrial appendage closure, Conformal Medical is also rapidly advancing its foam-based left atrial appendage closure device, CLAAS (this product is also a potential acquisition target for Medtronic in its subsequent competition with Boston Scientific, Abbott, and Johnson & Johnson in the electrophysiology field).

In the field of left atrial appendage closureAtriCure's AtriClip has always been the benchmark in this field. In the left atrial appendage occluder market, without an absolute technological advantage, it is difficult to compete with Boston Scientific and Abbott, and Medtronic is no exception. However, in the left atrial appendage closure field, competition is relatively less intense, and once there is a good product, it may stand out.AtriCure Controls the Market in ChinaA gap, successfully entering this field. Therefore, Medtronic prioritized this relatively less competitive field. As Medtronic expected, within less than two years after FDA approvalPenditureSales exceeded 10,000 sets.



Penditure

PenditureIt is the only left atrial appendage closure device that can be recaptured, repositioned, and redeployed during the surgical procedure.

PenditureByComposed of a closure clip and a disposable delivery system, with the closure clip preloaded in the delivery system..The closure clip is made byComposed of textured PEEK material (with a slight curvature at the distal tip) and a nitinol spring (providing clamping force). Depending on the size of the closure clip,PenditureIt can be divided into four specifications (the same as AtriCure products), with effective LAA closure lengths of 35mm, 40mm, 45mm, and 50mm.
Image
Penditure Advantages
  • No-fabric design to reduce the risk of inflammation

  • Tip-first closure helps provide a more complete and secure left atrial appendage occlusion.

  • Arc-shaped clip, better matching the atrial anatomy

  • Penditure Clip Can Be Recaptured, Redeployed, and Repositioned After Deployment to Ensure Precise Placement

  • A wide opening at the base provides a good surgical view, which may help in the correct placement of the clip.



Penditure Demonstration



Medtronic
Medtronic(Medtronic, Inc.) was founded in 1949, headquarteredHeadquartered in Minneapolis, Minnesota, USA, is the world's largest medical technology company, committed to providing lifelong treatment solutions for patients with chronic diseases.Medtronic's main products cover arrhythmia, heart failure, vascular diseases, heart valve replacement, extracorporeal heart support, minimally invasive heart surgery, malignant and non-malignant pain, movement disorders, diabetes, gastrointestinal diseases, urinary system diseases,Spinal diseases, neurological disorders, and surgeries in ophthalmology, otolaryngology, and other related fields.
图片

图片